Navigation Links
Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
Date:12/8/2012

che's media release issued earlier today.)

Currently, MabThera is available as an IV formulation. MabThera SC uses Halozyme's Enhanze™ Technology which enables the injection of large volumes of a medication under the skin. In a clinical study, patients were able to receive MabThera over approximately 5 minutes via SC injection versus a few hours with IV-infused MabThera.

About Halozyme

Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, that increase the absorption and dispersion of biologics. Halozyme's pipeline addresses therapeutic areas, such as diabetes, oncology and dermatology that have significant unmet medical need. The Company markets HYLENEX® recombinant (hyaluronidase human injection) and has partnerships with Roche, Baxter, ViroPharma and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at www.halozyme.com.

Safe Harbor Statement

In addition to historical information, the statements set forth above include forward-looking statements (including, without limitation, statements concerning the potential regulatory approval and commercial availability of MabThera SC and the potential benefits and attributes of MabThera SC) that involve risk and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements are also identified through use of the words "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of simila
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Halozyme Therapeutics To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
2. Halozyme to Host Third Quarter Financial Results Conference Call
3. Halozyme Reports Second Quarter 2012 Financial Results
4. Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
5. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
6. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
7. Halozyme Reports First Quarter 2012 Financial Results
8. Halozyme to Host First Quarter 2012 Financial Results Conference Call
9. Jury for 2012 Intercultural Innovation Award Announced
10. MEK162 Registration Path Announced
11. Hanmi and Kinex Announced Korean FDA Allowance of the KX01 IND Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Minn. , Aug. 1, 2014 ... medical technologies company, announced today that it has ... held manufacturer of cardiorespiratory diagnostic products based in ... MediSoft has served the European cardiorespiratory diagnostics market ... 2013 revenues of approximately €4.7 million ($6.3 million) ...
(Date:8/1/2014)... 1, 2014 Dyadic International, Inc. ("Dyadic") (OTCQX: ... technologies are used to develop, manufacture and sell enzymes ... and industrial enzyme industries, announced today that it will ... June 30, 2014 after market close on Thursday, August ... day at 5:00 p.m. Eastern Time to discuss those ...
(Date:7/31/2014)... 2014  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ; ... , Chief Business Officer and Executive Vice President. Mr. Singh ... 30. "Sorrento is deeply saddened and shocked by ... thoughts go to Amar,s family and friends," said Henry ... Mr. Singh joined Sorrento in January 2014 from ...
Breaking Medicine Technology:MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 2MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 3MGC Diagnostics Corporation Completes Acquisition of MediSoft SA 4Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 3Sorrento Announces the Unexpected Death of its Chief Business Officer 2
... Oct. 8 Breast-Specific Gamma Imaging (BSGI), a molecular ... resonance imaging (MRI) for detecting breast carcinoma when used ... and is substantially less expensive than MRI, according to ... Oncology Breast Cancer Symposium in San Francisco, California. , ...
... Calif., Oct. 8 Endologix, Inc. (Nasdaq: ELGX ), ... that it has become aware that Cook Medical has filed ... alleging that Endologix infringes two of Cook,s U.S. patents. , ... have just become aware of the lawsuit filed by Cook ...
Cached Medicine Technology:Breast-Specific Gamma Imaging Proves Cost-Effective for Pre-Surgical Planning of Patients with Known Cancer Diagnosis 2Endologix Comments on Alleged Patent Infringement 2
(Date:8/1/2014)... NY (PRWEB) August 01, 2014 Ticket Down ... at Maple Lane Farms in Knoxville/Greenback, TN; Ingram Farms ... Whitehurst Cattle Farm in Archer/Gainesville, FL. Luke Bryan is currently ... with Lee Brice and Cole Swindell. Bryan is responsible for ... world each summer and this year, just because the summer ...
(Date:8/1/2014)... at the Institute of Bioengineering and Nanotechnology (IBN), ... Singapore (NCCS) have co-developed the first molecular test ... in kidney cancer patients. This breakthrough was recently ... top urology journal. , According to IBN ... our expertise in molecular diagnostics and cancer research, ...
(Date:8/1/2014)... CapsCanada, a leading provider of ... new K-CAPS® (HPMC capsules) manufacturing facility in Lakeshore, ... last year while experiencing growing global demand for ... “KCAPS® are currently sold in more than 60 ... to other HPMC capsules, K-CAPS® have exceptional appearance ...
(Date:8/1/2014)... Hills, CA (PRWEB) August 01, 2014 ... has found that carbohydrates may contribute to the ... genetically predisposed to the disease. The study was authored ... it, carbohydrates were found to cause intestinal cells to ... more susceptible to colorectal cancer. , “What’s interesting ...
(Date:8/1/2014)... South Jordan, Utah (PRWEB) August 01, 2014 ... selling company MonaVie, who completes its 500th week of ... paid since the company was founded in January 2005 ... 39 countries throughout the world. The company pays commissions ... HKD, HUF, ILS, JPY, MYR, MXN, NZD, PLN, USD, ...
Breaking Medicine News(10 mins):Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 2Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 3Health News:Luke Bryan Tickets at Maple Lane Farms in Knoxville, Ingram Farms in Auburn, Cross Creek Place in Tallahassee & Whitehurst Cattle Farm in Gainesville Now Available 4Health News:Taking the guesswork out of cancer therapy 2Health News:Taking the guesswork out of cancer therapy 3Health News:Carbs May Contribute to Colon Cancer 2Health News:MonaVie Records 500th Commission Week, Having Paid Out More Than $1.4B in Distributor Commissions 2
... ... shows vacations with animals will help the family bond. Spending quality time with the family often ... ... families are finding it exciting and different to spend their vacations at a Dude or Guest ...
... ... Legal Hold Pro™ service into doeDiscovery™. Further expanding doeLegal,s capabilities across the entire spectrum ... to offer increased value to all eDiscovery clients. , ... (PRWEB) May 14, 2010 -- doeLegal, ...
... essays look at ethical issues arising from new neuroimaging ... severe brain injury might be able to communicate. ... Authors: J. Andrew Billings, Larry R. Churchill, and Richard ... or a meaningful existence? The authors contend that ...
... ... luminaries in science , ... New York, NY (Vocus) May 13, 2010 -- Mount Sinai School of Medicine ... field of genetics and human genome research, and renowned humanists whose work has advanced ...
... Recognizing ... by cancer, CIGNA expands access to all Cancer Treatment Centers of America physicians and facilities. ... Chicago, IL (PRWEB) May ... customers who have been touched by cancer, CIGNA has entered into a new agreement that ...
... affects 1 in 20 people over age 65, experts ... By treating the common irregular heartbeat known as atrial ... prevent Alzheimer,s disease and other forms of dementia, new ... of the heart beat chaotically, causing blood to pool ...
Cached Medicine News:Health News:Independent Study Reveals Family Bonds made Stronger on Vacations where Animals are Involved 2Health News:Independent Study Reveals Family Bonds made Stronger on Vacations where Animals are Involved 3Health News:Independent Study Reveals Family Bonds made Stronger on Vacations where Animals are Involved 4Health News:doeLegal and Zapproved Sign Alliance to Add Legal Hold Pro to Suite of Powerful Online Legal Solutions 2Health News:doeLegal and Zapproved Sign Alliance to Add Legal Hold Pro to Suite of Powerful Online Legal Solutions 3Health News:The Hastings Center Report table of contents for May/June 2010 2Health News:The Hastings Center Report table of contents for May/June 2010 3Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 2Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 3Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 4Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 5Health News:Mount Sinai School of Medicine Commencement Honors Leaders in Genetics and Global Health 6Health News:CIGNA and Cancer Treatment Centers of America Reach New Agreement 2Health News:Treating Common Irregular Heartbeat Might Also Ward Off Alzheimer's 2Health News:Treating Common Irregular Heartbeat Might Also Ward Off Alzheimer's 3
The Ultima 2000 SE is flexible in meeting the needs of both office and operating room use. It is the answer for the clinical practice with a wide range of ophthalmic demands looking for minimal risk ...
Practice-oriented ophthalmic laser systems for photodisruption....
Magnetic Farnsworth D15 kit Magnets move the color disks. Protects disks from fingerprints. Keeps all the disks in one place. Clear glass insures accurate color perception. Makes color testing fun....
... D15 test is used to ... defect vs normal. Farnsworth D15 ... permit the patient to select ... the box is closed and ...
Medicine Products: